Asked by: Jim Shannon (Democratic Unionist Party - Strangford)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, if she will have discussions with NHS England on the effectiveness of its Commercial Framework in tackling challenges presented by the appraisal and reimbursement system when applied to combination medicines and medicines with multiple indications.
Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)
As part of the 2024 voluntary scheme for branded medicines pricing, access, and growth, NHS England has committed to undertake two consultations on its Commercial Framework for New Medicines. The first of these will be launched in summer 2024 and will align with the Competition and Markets Authority’s (CMA) statement on combination medicines. In addition, it will be more explicit about the approach taken for assessing the eligibility of medicines treating multiple indications to qualify for indication specific pricing mechanisms.
Following the first consultation, a revised framework will be published by the end of 2024, and engagement with pharmaceutical companies and patient groups on these issues is already taking place.
Asked by: Jim Shannon (Democratic Unionist Party - Strangford)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 7 March 2024 to Question 15636 on Blood Cancer: Drugs, on what date her Department first became aware of challenges presented by the appraisal of combination therapies; and what solutions her Department is considering with NHS England to ensure continued equal access to combination medicines for multiple myeloma across the UK.
Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)
NHS England, the National Institute for Health and Care Excellence (NICE), and the Association of the British Pharmaceutical Industry (ABPI) worked closely with the Competition and Markets Authority (CMA) over a number of years on the CMA’s statement on combination therapies, published in November 2023.
The steps taken by the CMA provide a clear commercial position that means that deals involving multiple drugs licensed by different companies can now be agreed under specific circumstances. This has been welcomed by the ABPI as an opportunity to unlock the door to more transformative combination therapies on the National Health Service.
Asked by: Marsha De Cordova (Labour - Battersea)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether her Department plans to undertake a review of vision rehabilitation provision across England.
Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)
The Department is not planning to undertake a review of vision rehabilitation provision across England. Under the Care Act 2014, local authorities are responsible for commissioning social care services, including reablement.
Guidance to support the implementation of the Care Act 2014 says local authorities should consider securing specialist qualified rehabilitation and assessment provision, whether in-house, or contracted through a third party, to ensure that the needs of people with sight loss are correctly identified and their independence maximised. Certain aspects of independence training with sight impaired and severely sight impaired people require careful risk management, and should only be undertaken by professionals with relevant experience and training.
Asked by: Marion Fellows (Scottish National Party - Motherwell and Wishaw)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what recent discussions she has had with the Secretary of State for Work and Pensions on the potential impact of the level of statutory sick pay on public health.
Answered by Helen Whately - Minister of State (Department of Health and Social Care)
The government keeps Statutory Sick Pay policy under review.
I am clear that good work is good for you and our focus is on how we can keep people in work or get them back to work more quickly. That is why we are reforming the fit note process.
This is alongside our investment in Universal Support and Access to Work focussed on helping disabled people and those with health conditions return to and remain in work.
Asked by: Daniel Zeichner (Labour - Cambridge)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps she is taking to improve access to mental health services.
Answered by Helen Whately - Minister of State (Department of Health and Social Care)
We have been expanding and transforming mental healthcare
In 2022/23 3.6 million people received secondary mental healthcare, and 1.2 million people accessed NHS talking therapies
This is an increase in the number of people receiving NHS mental health support of around 30% in just three years.
Asked by: Marsha De Cordova (Labour - Battersea)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what data her Department (a) collects and (b) holds on waiting times for accessing vision rehabilitation support in England.
Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)
The Department does not collect or hold this information.
Asked by: Matt Hancock (Independent - West Suffolk)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 15 April 2024 to Questions 18426 and 18425 on Laboratories: Disease Control, if she will publish a breakdown of each expense category of (a) expenditure and (b) maintenance costs; for what reason Porton Down and Colindale scientific campus sites do not have separate operational costs for the Category 4 laboratories; what plans she has to ensure the long-term sustainability and effectiveness of Cat 4 laboratory sites; and what steps she is taking to protect the UK from (i) synthetically designed viruses and (ii) other new and emerging biothreats.
Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)
The Department of Health and Social Care has indicated that it will not be possible to answer this question within the usual time period. An answer is being prepared and will be provided as soon as it is available.
Asked by: Bell Ribeiro-Addy (Labour - Streatham)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, with reference to the report entitled A comparison of the care of Asian and White women who have experienced a stillbirth or neonatal death, published by the MBRRACE-UK Perinatal Confidential Enquiry on 14 December 2023, what recent discussions her Department has had with NHS England on ensuring that women (a) from lower socioeconomic backgrounds and (b) at risk of premature birth are offered the (i) tests and (ii) medication that are recommended by NHS guidelines.
Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)
Departmental and NHS England colleagues meet regularly to discuss initiatives to reduce disparities in maternity and neonatal outcomes, and pre-term births. NHS England has invested £6.8 million into their Equity and Equality guidance, which focuses on actions to reduce disparities for women and babies, including for those living in the most deprived areas. It sets out actions and expectations on Local Maternity and Neonatal Systems to consider complex social factors and adhere to the National Institute for Health and Care Excellence’s guidelines regarding maternity care.
All National Health Service trusts are now implementing the Saving Babies’ Lives Care Bundle (SBLCB), which provides up-to-date, evidence-based best practice regarding reducing perinatal mortality, including guidance around reducing preterm birth. The SBLCB recommends a universal risk assessment of all women for preterm birth at their antenatal booking appointment, with those at higher and intermediate risk being offered a care pathway designed to reduce the chances of preterm birth.
Asked by: Baroness Merron (Labour - Life peer)
Question to the Department of Health and Social Care:
To ask His Majesty's Government what assessment they have made of the potential impact on the mental health and wellbeing of secondary care staff if their partnership with NHS Practitioner Health is ended after the 12-month review period.
Answered by Lord Markham - Parliamentary Under-Secretary (Department of Health and Social Care)
We recognise that the NHS Practitioner Health service is valued by many doctors. NHS England is reviewing the service as part of a wider review of its mental health and wellbeing offer to National Health Service staff. It was confirmed on 15 April 2024 that the service will continue to accept new patients from primary and secondary care whilst this review is undertaken over the next 12 months. NHS England will assess the impact and confirm future arrangements once the review has been completed.
Asked by: Julian Sturdy (Conservative - York Outer)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps her Department has taken to improve care for people with Parkinson's disease.
Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)
I would like to thank my Honourable friend who is a tireless campaigner on this issue.